10x Genomics, Inc.
TXG- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001770787
In the last 90 days, 10x Genomics, Inc. insiders filed 0 open-market purchases and 11 sales; 393 institutions reported holding it in 13F filings for Q2 2026, worth $4.92B in total; superinvestors ARK Invest and Duquesne Family Office hold it.
13F holders, Q1 2022
Institutional positions in 10x Genomics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 313
- −47 vs. Q4 2021
- Shares held
- 82.8M
- +3.77M (+4.8%) vs. Q4 2021
- Total value
- $6.30B
- −$5.44B (−46.4%) vs. Q4 2021
- New holders
- 50
- 135 more added
- Sold out
- 97
- 71 more reduced
5 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 393 | $4.92B |
| Q1 2026 | 332 | $2.66B |
| Q4 2025 | 323 | $2.01B |
| Q3 2025 | 317 | $1.44B |
| Q2 2025 | 297 | $1.42B |
| Q1 2025 | 274 | $995.9M |
| Q4 2024 | 273 | $1.50B |
| Q3 2024 | 266 | $2.36B |
| Q2 2024 | 261 | $2.05B |
| Q1 2024 | 290 | $3.89B |
| Q4 2023 | 275 | $5.37B |
| Q3 2023 | 257 | $3.75B |
| Q2 2023 | 274 | $4.98B |
| Q1 2023 | 259 | $5.03B |
| Q4 2022 | 268 | $3.19B |
| Q3 2022 | 234 | $2.45B |
| Q2 2022 | 254 | $3.91B |
| Q1 2022 | 313 | $6.30B |
| Q4 2021 | 365 | $11.9B |
| Q3 2021 | 332 | $11.5B |
| Q2 2021 | 342 | $15.3B |
| Q1 2021 | 324 | $12.8B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding 10x Genomics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Central Trust Co | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| TSFG, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Amplius Wealth Advisors, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Zions Bancorporation, N.A. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Venrock Management VI, LLC | – | – | – | – | Not filed |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |
| Harbour Investments, Inc. | – | – | – | – | Not filed |
| Carroll Financial Associates, Inc. | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |